• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
?
-

Resources for You

Hizentra

STN:  BL 125350
Proper Name: Immune Globulin Subcutaneous (Human), 20% Liquid
Tradename: Hizentra
Manufacturer: CSL Behring AG, License #1766
Indication:

  • Treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.

 

 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002